Global Veterinary Infectious Disease Diagnostics Market is valued approximately at USD 1.30 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 8.40% over the forecast period 2019-2026. Growing demand for advanced veterinary infectious disease diagnostic tools, increasing demand for animal-derived food products, growth in companion animal population, rising demand for pet insurance, an increasing number of veterinary practitioners in developed economies, and growing disease control & disease prevention measures are some of the key factors driving the veterinary infectious disease diagnostics market. However, lack of a skilled workforce impedes the growth of the market over the forecast period of 2019-2026.
The regional analysis of global Veterinary Infectious Disease Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as increasing adoption of pets, rising demand for infectious disease diagnostics in food-producing animals, and the growing incidences of zoonotic diseases would create lucrative growth prospects for the Veterinary Infectious Disease Diagnostics market across Asia-Pacific region.
Major market player included in this report are:
IDEXX Laboratories, Inc. (US)
Zoetis, Inc. (US)
QIAGEN N.V. (Indical GmbH) (Germany)
Thermo Fisher Scientific, Inc. (US)
Neogen Corporation (US)
Virbac (France)
BioMerieux SA (France)
IDVet (France)
Randox Laboratories, Ltd. (UK)
Heska Corporation (US)
Creative Diagnostics (US)
URIT Medical Electronic Group Co., Ltd (China)
NTBIO Diagnostics, Inc. (Canada)
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the , to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Immunodiagnostics (Lateral Flow Assays, ELISA)
Molecular Diagnostics
By Animal:
Companion
Farm
By End-User:
Lab
Hospital
Clinics
PoC
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2016, 2017
Base year - 2018
Forecast period - 2019 to 2026
Target Audience of the Global Veterinary Infectious Disease Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
